Open AccessAbstract 12: Antitumor activity of lenvatinib in combination with everolimus or an anti-PD1 antibody in preclinical RCC models
Author(s) -
Yusuke Adachi,
Takayuki Kimura,
Masahiro Matsuki,
Junji Matsui,
Yasuhiro Funahashi
Publication year - 2018
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2018-12
Subject(s) - lenvatinib , everolimus , medicine , cancer research , pharmacology , cabozantinib , renal cell carcinoma , oncology , sorafenib , hepatocellular carcinoma